Apeiron RIA’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-8,294
| Closed | -$606K | – | 208 |
|
|
2023
Q3 | $606K | Sell |
8,294
-4,422
| -35% | -$323K | 0.21% | 84 |
|
|
2023
Q2 | $1.06M | Buy |
12,716
+429
| +3% | +$35.7K | 0.36% | 50 |
|
|
2023
Q1 | $936K | Buy |
12,287
+5,761
| +88% | +$439K | 0.32% | 53 |
|
|
2022
Q4 | $542K | Buy |
6,526
+14
| +0.2% | +$1.16K | 0.21% | 89 |
|
|
2022
Q3 | $510K | Buy |
+6,512
| New | +$510K | 0.23% | 81 |
|